Multicellular living organisms and unmodified parts thereof and – Method of introducing a polynucleotide molecule into or... – The polynucleotide contains a tissue – organ – or cell...
Reexamination Certificate
2000-10-10
2003-12-23
McElwain, Elizabeth F. (Department: 1638)
Multicellular living organisms and unmodified parts thereof and
Method of introducing a polynucleotide molecule into or...
The polynucleotide contains a tissue, organ, or cell...
C800S278000, C800S298000, C800S295000, C800S320000, C800S317000, C800S322000, C800S279000, C435S320100, C435S419000, C435S468000, C536S023600, C536S024100
Reexamination Certificate
active
06667427
ABSTRACT:
FIELD OF THE INVENTION
The invention relates to nucleotide sequences and proteins for anti-pathogenic agents and their uses, particularly the genetic manipulation of plants with genes and promoters that enhance disease resistance.
BACKGROUND OF THE INVENTION
Among the causal agents of infectious diseases of crop plants, phytopathogenic fungi play the dominant role, not only by causing devastating epidemics, but also through the less spectacular although persistent and significant annual crop yield losses that have made fungal pathogens a serious economic factor. All flowering plant species are attacked by pathogenic fungi. To colonize plants, fungal microorganisms have evolved strategies to invade plant tissue, to optimize growth in the plant, and to propagate. Bacteria and viruses, as well as some opportunistic fungal parasites, often depend on natural openings or wounds for invasion. In contrast, many true phytopathogenic fungi have evolved mechanisms to actively traverse the plants outer structural barriers, the cuticle and the epidermal cell wall. To gain entrance, fungi generally secrete a cocktail of hydrolytic enzymes.
Despite the large number of microorganisms capable of causing disease, most plants are resistant to any given pathogen. The defense mechanisms utilized by plants can take many different forms, ranging from passive mechanical or preformed chemical barriers, which provide non-specific protection against a wide range of organisms, to more active host-specific responses that provide host- or varietal-specific resistance.
A hypersensitive response (HR) that is elaborated in response to invasion by all classes of pathogens is the most common feature associated with active host resistance. In most cases, activation of the HR leads to the death of cells at the infection site, which results in the restriction of the pathogen to small areas immediately surrounding the initially infected cells. At the whole-plant level, the HR is manifested as small necrotic lesions. The number of cells affected by the HR is only a small fraction of the total in the plant, so this response obviously contributes to the survival of plants undergoing pathogen attack.
In plants, robust defense responses to invading phytopathogens often conform to a gene-for-gene relationship. Resistance to a pathogen is only observed when the pathogen carries a specific avirulence (avr) gene and the plant carries a corresponding resistance (R) gene. Because avr-R gene-for-gene relationships are observed in many plant-pathogen systems and are accompanied by a characteristic set of defense responses, a common molecular mechanism underlying avr-R gene-mediated resistance has been postulated. Thus, disease resistance results from the expression of a resistance gene in the plant and a corresponding avirulence gene in the pathogen and is often associated with the rapid, localized cell death characteristic of the hypersensitive response. R genes that respond to specific bacteria, fungal, or viral pathogens have been isolated from a variety of plant species and several appear to encode cytoplasmic proteins.
The development of new strategies to control diseases is the primary purpose of research on plant-pathogen interactions. These include, for example, the identification of essential pathogen virulence factors and the development of means to block them, or the transfer of resistance genes into crop plants from unrelated species. An additional benefit is a better understanding of the physiology of the healthy plant through a study of the metabolic disturbances caused by plant pathogens.
SUMMARY OF THE INVENTION
Anti-pathogenic compositions and methods for their use are provided. The compositions comprise anti-pathogenic polypeptides, the nucleotide sequences encoding these polypeptides and the nucleotide sequences comprising the regulatory regions of these sequences. Particularly, sunflower pathogenesis-related protein 5-2 (PR5-2) and blight associated protein (BAP), as well as fragments and variants thereof, are provided.
The compositions are useful in protecting plants from invading pathogenic organisms. One method involves stably transforming a plant with nucleotide sequences of the invention to engineer broad-spectrum disease resistance in the plant. The nucleotide sequences are expressed from a promoter capable of driving expression in a plant cell. A second method involves controlling plant pathogens by applying an effective amount of an anti-pathogenic protein or composition to the plant environment. Additionally, the nucleotide sequences of the invention are useful as genetic markers in disease-resistance breeding programs.
Promoters of the genes of the invention find use as defense-inducible promoters. Such promoters may be used to express other coding regions, particularly other anti-pathogenic genes, including disease and insect resistance genes.
The compositions of the invention additionally find use in agricultural and pharmaceutical compositions as antifungal and antimicrobial agents. For agricultural purposes, the compositions may be used in sprays for control of plant disease. As pharmaceutical compositions, the agents are useful as antibacterial and antimicrobial treatments.
Thus, the methods of the invention find use in controlling pests, including fungal pathogens, viruses, nematodes, insects, and the like. Transformed plants, plant cells, plant tissues, and seeds, as well as methods for making such transformed compositions are additionally provided.
REFERENCES:
patent: 5801028 (1998-09-01), Bressan et al.
patent: 0332104 (1989-09-01), None
patent: 0392225 (1990-10-01), None
patent: 0460753 (1991-12-01), None
patent: 1 033 405 (2000-09-01), None
patent: WO 92/17580 (1992-10-01), None
patent: WO 93/05153 (1993-03-01), None
patent: WO 94/08010 (1994-04-01), None
patent: WO 95/19443 (1995-07-01), None
patent: WO 98/13478 (1998-04-01), None
patent: WO 99/04012 (1999-01-01), None
patent: WO 99/50428 (1999-10-01), None
patent: WO 00/11175 (2000-03-01), None
patent: WO 00/11196 (2000-03-01), None
patent: WO 00/68405 (2000-11-01), None
patent: WO 00/78983 (2000-12-01), None
International Search Report mailed Jun. 5, 2001 for International Application No. PCT/US00/28489 filed Oct. 13, 2000.
U.S. patent application Ser. No. 09/589,733, Bidney et al., filed, Jun. 8, 2000.
Ceccardi et al. (1998) “A Novel Protein Associated with Citrus Blight Has Sequence Similarities to Expansin,”Plant Molecular Biology 38:775-783.
Datta et al. (1999) Database BIOSIS Accession No. PREV199903310941, “Over-Expression of the Cloned Rice Thaumatin-Like Protein (PR-5) Gene in Transgenic Rice Plants Enhances Environmental Friendly Resistance to Rhizoctonia Solani Causing Sheath Blight Disease,” Abstract,Theorectical and Applied Genetics 98(6-7):1138-1145. (XP-002151843).
Gentzbittel et al. (1998), “Cloning of Molecular Markers for Disease Resistance in Sunflower,Helianthus annus L.,” Chem. Appl. Genet.96:519-525.
Hu et al. (1997) “Cloning and Expression of a PR5-Like Protein fromArabidopsis: Inhibition of Fungal Growth by Bacterially Expressed Protein,”Plant Molecular Biology 34:949-959.
Jung et al. (1993) “Sunflower (Helianthus annuus L.) Pathogenesis-Related Proteins,”Plant Physiol. 101:873-880.
Jung et al. (1995) “Different Pathogenesis-Related-Proteins and Expressed in Sunflower (Helianthus annuus L.) in Response to Physical, Chemical and Stress Factors,”J. Plant Physiol. 145:153-160. (XP-000960401).
Koiwa et al. (1997) Database BIOSIS Accession No. PREV199799712464, “Purification and Characterization of Tobacco Pathogenesis-Related Protein PR-5d, an Antifungal Thaumatin-Like Protein,” Abstract,Plant and Cell Physiology 38(7):783-791. (XP-002151842).
Liu et al. (1994) “Osmotin Overexpession in Potato Delays Development of Disease Symptoms”Proc. Natl. Acad. Sci USA 91:1888-1892.
Liu et al. (1995) “Fine Structure and Function of the Osmotin Gene Promoter”Plant Molecular Biology 29:1015-1026.
Liu et al. (1996) Database BIOSIS Accession No. PREV199799414966, “In VivoandIn VitroActivity of Truncated Osmotin That is Secreted
Bao Zhangmeng
Duvick Jonathan P.
Hu Xu
Lu Guihua
Ibrahim Medina A.
McElwain Elizabeth F.
Pioneer Hi-Bred International , Inc.
Pioneer Hi-Bred International Inc.
LandOfFree
Sclerotinia-inducible promoters and their uses does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Sclerotinia-inducible promoters and their uses, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Sclerotinia-inducible promoters and their uses will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3149416